Loading...
Back to narrative

AnalystConsensusTarget updated the narrative for EDEN

Update shared on 12 Sep 2025

Fair value Decreased 1.55%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-37.6%
7D
2.1%

Edenred’s consensus price target was slightly reduced to €39.10 as analysts anticipate Italian market headwinds and a lack of near-term catalysts despite solid cost control and ongoing long-term confidence from major firms.


Analyst Commentary


  • Bearish analysts lowered price targets primarily due to expected upcoming headwinds in the Italian market.
  • Strong cost control initiatives helped drive EBITDA like-for-like growth, providing some resilience against sector challenges.
  • Q2 growth remained unchanged, but analysts saw no inflection point signalling material improvement ahead.
  • Mixed sentiment persists, with Overweight and Buy ratings maintained despite lower targets, reflecting continued longer-term confidence from major firms such as JPMorgan and Morgan Stanley.
  • Neutral and Hold ratings from other analysts highlight market uncertainty and a lack of strong near-term catalysts for outperformance.

What's in the News


  • Edenred SE to hold a board meeting to consider and approve interim consolidated financial statements for the six months ended June 30, 2025.

Valuation Changes


Summary of Valuation Changes for Edenred

  • The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from €39.72 to €39.10.
  • The Consensus Revenue Growth forecasts for Edenred remained effectively unchanged, moving only marginally from 9.3% per annum to 9.2% per annum.
  • The Net Profit Margin for Edenred remained effectively unchanged, moving only marginally from 20.21% to 20.05%.

Have other thoughts on Edenred?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.